2013 Conditions Events Treatment 
Cannabis Law Report
JULY 27, 2021
The longitudinal study showed that individuals who used artisanal cannabidiol (CBD) products reported better quality of life, lower psychiatric symptom severity and fewer medication-related adverse events compared with those not using CBD. This study represents a refreshing collaboration of scientists, clinicians, patients and advocates.
Miss Marijuana
JUNE 15, 2019
PTSD is recognized as a Trauma and Stressor-related Disorder in the DSM-5 , and develops through a severely distressing mental and/or physical event, like a terrorist attack, military combat, serious accidents or sexual violence. comorbid psychiatric conditions, “including anxiety, mood, personality and sleep disorders.”.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
The Cannigma
OCTOBER 9, 2021
The overall effects appear to be a reduction in inflammation, sensory activity and bladder contractility, resulting in prolonged bladder emptying of varied significance (Hedlund, 2013). According to the National Association of Incontinence, approximately 25 million Americans are suffering from episodes of involuntary loss of urine.
CannaEffect
OCTOBER 31, 2017
After nearly 20 years of crippling pain and bizarre medical treatments, Heather can walk her three dogs in the sunshine and smile thanks to Real Scientific Hemp Oil, CBD oil by HempMeds. The couple met again in 2011 and were married in 2013. “I’ve Heather tried just about every pain treatment method on the market. “I’ve
CannaMD
JUNE 6, 2020
A 2013 study published in Frontiers in Psychology found that the synthetic cannabinoid dronabinol , made to mimic THC, could improve symptoms in those suffering from sleep apnea. MARIJUANA MAY HELP THOSE WITH SLEEP APNEA. A study published in the peer-reviewed journal Sleep produced similar findings. Find Out if You Qualify. Get Started.
Cannabis Law Report
JANUARY 20, 2022
Eleusis designed ELE-Psilo, a proprietary psilocybin-based drug candidate that is formulated for IV infusion and in development for the treatment of depression. Eleusis secured an Innovation Passport Designation for ELE-Psilo in adult treatment-resistant depression under the U.K. About Eleusis.
Greencamp
DECEMBER 4, 2018
This reaction is dependent on the type of cell that was activated through these receptors, but also on the condition our body is struggling with. The way a specific cell reacts when a cannabinoid activates its receptor is also dependent on the type of condition that an organism is afflicted with. Endocannabinoid system discovery.
Expert insights. Personalized for you.
105 
Let's personalize your content